US meningitis cases climb to 205 as outbreak worsens

Fungal meningitis tied to a contaminated steroid has affected 205 people in a worsening outbreak of the infection that has killed 15 people in the United States, officials said Sunday.

Fourteen states have been affected by the outbreak, the said. On Saturday, it had reported 198 cases nationwide.

The situation is particularly bad in Tennessee, where 53 cases including six deaths have been reported. Michigan follows, with 41 cases and Virginia with 34 cases.

Other states reporting cases include Florida, Illinois, Indiana, Maryland, New Jersey, North Carolina, Ohio and Texas.

The situation took a turn for the worse in a little more than a week. On October 6, the had reported 64 cases including seven deaths.

Almost 14,000 people in 23 states may have received contaminated doses of the steroid—typically injected into the spine to treat back pain—from the New England Compounding Center in Massachusetts, which has since shut down its operations and recalled all of its products.

Generally, meningitis symptoms should appear between one and four weeks after the injection, but in some cases they could only show up several months later, according to .

The rare strain of the disease, which inflames the protective membranes covering the brain and spinal cord, requires a lengthy hospital stay and intravenous anti-fungal medications. It is not contagious in this form.

add to favorites email to friend print save as pdf

Related Stories

US tainted drug outbreak rises to 185 cases

Oct 12, 2012

The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.

US meningitis outbreak death toll rises to 15

Oct 14, 2012

The death toll from an unprecedented US meningitis outbreak tied to a tainted steroid jumped to 15 after another person died from a fungal form of the disease, health authorities said Saturday.

US pharmacy linked to outbreak issues wide recall

Oct 07, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Recommended for you

Families wait in agony for word on Ebola patients

4 hours ago

First the ring tone echoed outside the barbed-wire-topped walls of the Ebola clinic. Then came the wails of grief, as news spread that 31-year-old Rose Johnson was dead just days after she was brought here ...

China to open first high security bio laboratory

5 hours ago

China's first high-security biosafety laboratory will be ready for use by December, in a move hailed as a "crucial" moment in the fight against pathogens such as the Ebola virus, officials said Tuesday.

US Ebola labs, parts for clinic arrive in Liberia

6 hours ago

U.S. mobile Ebola labs should be up and running in Liberia this week, and American troops have broken ground for a field hospital, as the international community races to increase the ability to care for ...

User comments